Using New Oral Anticoagulants in Patients Undergoing Major Orthopedic Surgery

被引：0
|
作者：
Anne R. Bass
机构：
[1] Weill Cornell Medical College,Hospital for Special Surgery
来源：
Current Rheumatology Reports | 2015年 / 17卷
关键词：
Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Total knee replacement; Total hip replacement; Orthopedic surgery; Venous thromboembolism; Anticoagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Four new oral anticoagulants (NOAC), apixaban, rivaroxaban, edoxaban, and dabigatran, are now available in the USA; however, only apixaban and rivaroxaban are FDA approved for the prevention of venous thromboembolism following orthopedic surgery. Apixaban, rivaroxaban, and edoxaban’s anticoagulant activity can be measured using a chromogenic anti-factor Xa assay but there is no widely available means of measuring dabigatran blood levels. None of the NOAC has an antidote. Dabigatran is 80 % renally excreted, and patients with atrial fibrillation taking dabigatran for stroke prevention should stop the drug 4–5 days prior to major orthopedic surgery. Apixaban, rivaroxaban, and edoxaban should be held for 48 h preoperatively in this setting.
引用
收藏
相关论文
共 50 条
  • [41] New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation
    Ando, Giuseppe
    Trio, Olimpia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 244 - 246
  • [42] NEW ORAL ANTICOAGULANTS Safety of new oral anticoagulants in high risk patients
    Dalgleish, Stephen
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [43] Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
    Weitz, Jeffrey I.
    Healey, Jeffrey S.
    Skanes, Allan C.
    Verma, Atul
    CIRCULATION, 2014, 129 (16) : 1688 - 1694
  • [44] Management of patients on direct oral anticoagulants requiring urgent orthopedic surgery: role of plasmatic drug concentration
    Giani, Marco
    Forlini, Clarissa
    Coccini, Veronica
    Corsi, Maurizio
    Turati, Marco
    Vitullo, Valeria
    Foti, Giuseppe
    MINERVA ANESTESIOLOGICA, 2020, 86 (06) : 685 - 686
  • [45] Medical Crowdfunding for Patients Undergoing Orthopedic Surgery
    Durand, Wesley M.
    Johnson, Joseph R.
    Eltorai, Adam E. M.
    Daniels, Alan H.
    ORTHOPEDICS, 2018, 41 (01) : E58 - E63
  • [46] Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs)
    Irina S. Barequet
    Tzukit Zehavi-Dorin
    Nirit Bourla
    Ilia Tamarin
    Joseph Moisseiev
    Ophira Salomon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 2671 - 2676
  • [47] Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs)
    Barequet, Irina S.
    Zehavi-Dorin, Tzukit
    Bourla, Nirit
    Tamarin, Ilia
    Moisseiev, Joseph
    Salomon, Ophira
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (12) : 2671 - 2676
  • [48] A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants
    Claxton, J'Neka S.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    Norby, Faye L.
    Chen, Lin Y.
    O'Neal, Wesley T.
    Chamberlain, Alanna M.
    Bengtson, Lindsay G. S.
    Alonso, Alvaro
    PLOS ONE, 2018, 13 (09):
  • [49] Prevention of venous thromboembolism in patients undergoing major orthopedic surgery in China: a qualitative study of patients' perceptions
    Xu, Yaping
    Zhao, Jing
    Chen, Yuzhao
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2018, 13
  • [50] Prevention of venous thromboembolism in patients undergoing major orthopedic surgery in China: a qualitative study of patients’ perceptions
    Yaping Xu
    Jing Zhao
    Yuzhao Chen
    Journal of Orthopaedic Surgery and Research, 13
12345